Paper · 34201848
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 29
Download this page as JSON| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,559,672 | Effects of Chitosan Oligosaccharides on Human Blood Components. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30559672 | PubMed |
| 2 | 24,219,323 | Impact of Diet Composition on Blood Glucose Regulation. | Crit Rev Food Sci Nutr | 2016 | https://conductscience.org/library/papers/24219323 | PubMed |
| 3 | 18,255,211 | A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. | Food Chem Toxicol | 2008 | https://conductscience.org/library/papers/18255211 | PubMed |
| 4 | 20,508,640 | SGLT2 inhibition--a novel strategy for diabetes treatment. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/20508640 | PubMed |
| 5 | 15,563,878 | Effect of N-benzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. | Clin Chim Acta | 2005 | https://conductscience.org/library/papers/15563878 | PubMed |
| 6 | 25,516,476 | Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet. | Metabolism | 2015 | https://conductscience.org/library/papers/25516476 | PubMed |
| 7 | 29,628,262 | Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice. | Carbohydr Polym | 2018 | https://conductscience.org/library/papers/29628262 | PubMed |
| 8 | 199,593 | Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. | J Biol Chem | 1977 | https://conductscience.org/library/papers/199593 | PubMed |
| 9 | 31,744,059 | Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice. | Mar Drugs | 2019 | https://conductscience.org/library/papers/31744059 | PubMed |
| 10 | 22,173,168 | The interaction of hepatic lipid and glucose metabolism in liver diseases. | J Hepatol | 2012 | https://conductscience.org/library/papers/22173168 | PubMed |
| 11 | 21,099,258 | Long-term effects of chitosan oligosaccharide in streptozotocin-induced diabetic rats. | Islets | 2009 | https://conductscience.org/library/papers/21099258 | PubMed |
| 13 | 29,386,513 | Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. | Nat Commun | 2018 | https://conductscience.org/library/papers/29386513 | PubMed |
| 14 | 33,498,889 | Effects and Mechanisms of Chitosan and ChitosanOligosaccharide on Hepatic Lipogenesis and Lipid Peroxidation, Adipose Lipolysis, and Intestinal Lipid Absorption in Rats with High-Fat Diet-Induced Obesity. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33498889 | PubMed |
| 15 | 31,685,797 | Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial. | Nutr Diabetes | 2019 | https://conductscience.org/library/papers/31685797 | PubMed |
| 16 | 16,807,249 | CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16807249 | PubMed |
| 17 | 11,460,564 | Integration of biochemical and physiologic effects of insulin on glucose metabolism. | Exp Clin Endocrinol Diabetes | 2001 | https://conductscience.org/library/papers/11460564 | PubMed |
| 18 | 4,473,281 | Simple enzymatic determination of polysaccharide (glycogen) content of animal tissues. | Clin Chem | 1974 | https://conductscience.org/library/papers/4473281 | PubMed |
| 19 | 17,653,211 | The role of protein kinase C activation in diabetic nephropathy. | Kidney Int Suppl | 2007 | https://conductscience.org/library/papers/17653211 | PubMed |
| 20 | 19,799,852 | Establishment and characterization of a novel method for evaluating gluconeogenesis using hepatic cell lines, H4IIE and HepG2. | Arch Biochem Biophys | 2009 | https://conductscience.org/library/papers/19799852 | PubMed |
| 21 | 21,964,204 | Efficacy of chitooligosaccharides for the management of diabetes in alloxan induced mice: a correlative study with antihyperlipidemic and antioxidative activity. | Eur J Pharm Sci | 2011 | https://conductscience.org/library/papers/21964204 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/34201848/references